Stay updated with breaking news from Performance Enzymes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday. CDXS has been the subject of several other reports. Benchmark restated a buy rating and set a $9.00 price target on shares of Codexis in a research report on […]
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a sell rating to a hold rating in a research report released on Wednesday morning. A number of other equities analysts have also weighed in on CDXS. TD Cowen lowered Codexis from an outperform rating to a market perform rating and lowered their target price […]
StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report released on Tuesday morning. Several other analysts have also recently weighed in on CDXS. Stifel Nicolaus dropped their price objective on shares of Codexis from $9.00 to $5.00 and set a buy rating for the […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) insider Margaret Nell Fitzgerald purchased 11,834 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was purchased at an average price of $1.70 per share, for a total transaction of $20,117.80. Following the acquisition, the insider now owns 81,420 shares in the […]
Benchmark restated their buy rating on shares of Codexis (NASDAQ:CDXS – Free Report) in a research note released on Friday, Benzinga reports. Benchmark currently has a $9.00 price objective on the biotechnology company’s stock. CDXS has been the subject of several other reports. HC Wainwright cut Codexis from a buy rating to a neutral rating […]